LPCN
Lipocine Inc.
Nasdaq · usd
Lipocine Inc. (LPCN) trades at $1.45 (+0.69%) as of 4:22:18 PM EDT on Oct 26, 2026, -30.95% over the past month. Market cap is $11.87M, with 2.3 days to cover in short interest.
Stock performance
How Lipocine Inc. (LPCN) stock has performed from one day to one year, with its 52-week range.
- 1D
- +0.69%
- 1W
- -5.23%
- 1M
- -30.95%
- YTD
- -81.94%
- 1Y
- -48.58%
- 52-wk range
- $1.40 – $12.37
Key statistics
Today's trading snapshot for LPCN: day range, open, previous close, volume and market cap.
- Day range
- $1.40 – $1.45
- Open
- $1.44
- Prev close
- $1.44
- Volume
- 108.42K
- Market cap
- $11.87M
- Shares out
- 8.24M
Valuation and profitability ratios: P/E, P/S, ROE
Valuation and profitability ratios for Lipocine Inc.: P/E, P/S, P/B, ROE and more.
- P/E
- —
- P/S
- 9.42
- P/B
- 0.55
- P/FCF
- —
- ROE
- -54.4%
- ROA
- -49.7%
- Debt/Equity
- 0.00
- Div yield
- 0.00%
As of Oct 23, 2026
8-K filings
Material corporate events Lipocine Inc. has disclosed to the SEC on Form 8-K.
- Investor presentationOct 20, 2026
The Company has updated its corporate presentation that it uses when meeting with investors, analysts and others. The presentation is filed as Exhibit 99.1.
- Regulatory decisionOct 7, 2026
On October 7, 2026, the Company announced that Health Canada had approved TLANDO® for testosterone replacement therapy in adult males.
- Investor presentationSep 16, 2026
On September 16, 2026, the Company presented at H.C. Wainwright 28th Annual Global Investor Conference which was being held September 14 – 16, 2026, in New York City, NY. A copy of the presentation is furnished as Exhibit 99.1 to this report and incorporated by reference herein.
- Equity compensation grantAug 3, 2026
In connection with his appointment as a member of the Board of Directors, Mr. Grissinger will receive an initial stock option grant to purchase 2,000 shares of common stock of the Company.
- Annual meeting resultsJun 4, 2026
On June 3, 2026, the Company held its annual general meeting of shareholders, at which time the proposals described below were voted upon. The Company's shareholders elected for a one-year term four persons nominated for election as directors... The Company's shareholders voted upon and ratified the appointment of Tanner LLC as the Company's independent registered public accountants for the fiscal year ending December 31, 2026.
Dividend history and stock splits
Lipocine Inc.'s recent dividend payments and stock splits.
Dividends
No recent dividends.
Splits
- 1-for-17May 12, 2023
LPCN short interest
How heavily LPCN is shorted: shares short, days to cover and average daily volume.
- Days to cover
- 2.3
- Short interest
- 97.82K
- Avg volume
- 43.28K
As of · reported to FINRA twice monthly.
LPCN news
The latest news and headlines about Lipocine Inc. (LPCN).
- Here's Why You Should Add LPCN Stock to Your Portfolio NowpositiveZacks Investment Research· Oct 8, 2026
- Lipocine's PPD Phase 3 Study (LPCN 1154) Hits 80% Enrollment MilestonepositiveBenzinga· Dec 16, 2025
- Lipocine to Present at H.C. Wainwright 27th Annual Global Investment ConferenceneutralBenzinga· Sep 5, 2025
- Sarcopenia Clinical Trial Pipeline Appears Robust With 18+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsightpositiveGlobeNewswire Inc.· Apr 24, 2025
- Lipozem Reviews (2025): Consumer Reports on Lipozem Weight Loss FormulapositiveGlobeNewswire Inc.· Mar 21, 2025
Frequently asked questions
What is the Lipocine Inc. (LPCN) stock price today?
Lipocine Inc. (LPCN) is trading at $1.45 (+0.69% on the day) as of 4:22:18 PM EDT on Oct 26, 2026. Prices are delayed at least 15 minutes; real-time quotes are available from the Massive API.
What is Lipocine Inc.?
Lipocine Inc is a clinical-stage biopharmaceutical company that is engaged in research and development for the delivery of drugs using its proprietary delivery technology. Its principal operation is to provide oral delivery solutions for existing drugs.
What is the short interest in LPCN?
As of Sep 30, 2026, LPCN has 97.82K shares short and 2.3 days to cover.
What exchange is LPCN listed on?
Lipocine Inc. (LPCN) trades on Nasdaq in USD, in the PHARMACEUTICAL PREPARATIONS industry.
Build with AI
Build an analysis of LPCN with your agent
Point Claude or ChatGPT at the Massive MCP server and recreate this page from live data.
Connect the Massive MCP server (API reference: massive.com/docs/llms.txt) and build a LPCN analysis: the latest quote, key ratios (P/E, P/S, ROE), short interest, recent insider activity and the latest news.
Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.